Black warning labels removed from Hormone replacement therapy pill

In a landmark decision for women’s health, the U.S. Food and Drug Administration (FDA) has announced the removal of black box warnings from hormone replacement therapy (HRT) products used to treat menopause symptoms.  This significant change reflects updated scientific understanding and could impact treatment options for millions of women.